Oragenics Inc. Insider Trading

OGEN

Last 12 months

Insiders sold $197 and bought nothing on the open market.

None of the selling was scheduled in advance under a 10b5-1 plan. Director Fred Telling sold $197 on Dec 12, 2025, 18% of their stake, outside a plan. The last open-market buy by an executive or director was in Jun 2022.

Net open-market

−$197

0 buys · 1 sale

Under a 10b5-1 plan

of the value sold

Insiders who bought / sold

0 / 1

executives and directors

Last open-market buy

Jun 2022

Jun 17, 2022

Get an email when OGEN's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Dec 12, 2025	Fred Telling Director	SoldNo plan	210	$0.94	$197	18%	Form 4
Jun 17, 2025 – Jun 18, 2025	Odyssey Health, Inc. Large holder	SoldNo plan 2 parts	7,044	$4.32 average	30K	100%	Form 4
Jun 13, 2025 – Jun 16, 2025	Odyssey Health, Inc. Large holder	SoldNo plan 2 parts	10,000	$4.36 average	44K	59%	Form 4
Dec 6, 2024	Alan W Dunton Director	SoldNo plan	66	$0.36	$24	0.3%	Form 4
Dec 6, 2024	Fred Telling Director	SoldNo plan	3,597	$0.36	1K	9.4%	Form 4

Dec 12, 2025No plan
Fred Telling
Director · sold 210 at $0.94
$197
18% of stake
Jun 17, 2025 – Jun 18, 2025No plan
Odyssey Health, Inc.
Large holder · sold 7,044 at avg $4.32
30K
100% of stake
Jun 13, 2025 – Jun 16, 2025No plan
Odyssey Health, Inc.
Large holder · sold 10,000 at avg $4.36
44K
59% of stake
Dec 6, 2024No plan
Alan W Dunton
Director · sold 66 at $0.36
$24
0.3% of stake
Dec 6, 2024No plan
Fred Telling
Director · sold 3,597 at $0.36
1K
9.4% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch OGEN, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Pharmaceutical Preparations · Pick stocks to compare with OGEN

CompareIntrinsic value

BPTHBio-Path Holdings Inc.

$0.00+66.67%20

NTHINeonC Technologies Holdings

$3.17+3.26%10

ALTAltimmune, Inc.

$2.12+3.92%10

LNAILunai Bioworks Inc.

$0.16-30.17%10

IBOImpact Biomedical Inc.

$4.10+1.99%20

LYELLyell Immunopharma, Inc.

$15.43+43.27%10

GTBPGT Biopharma, Inc.

$4.84-8.16%20

BDPTBioadaptives Inc.

$0.00-5.88%25

Spot a number that looks wrong? Check it in OGEN's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing OGEN

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.